Literature DB >> 10553202

Immune mechanisms in pediatric neuropsychiatric disorders. Tourette's syndrome, OCD, and PANDAS.

R R Trifiletti1, A M Packard.   

Abstract

The authors have reviewed recent data supporting the presence of immune abnormalities in several neuropsychiatric disorders (TS, OCD, and PANDAS). Several groups agree that there is a subset of patients with TS and OCD (perhaps about 10%) for whom there is a clear streptococcal trigger, validating the PANDAS concept. Also, evidence of biochemical markers for TS and OCD have begun to emerge, namely D8/17 and antibrain antibodies, which suggest the presence of similar immune abnormalities, even in idiopathic cases. If this line of research reveals definable, and relatively specific, immune abnormalities in at least some cases of TS and OCD, it will likely have important implications for the diagnosis and treatment of these common neuropsychiatric disorders, particularly in children who respond poorly to conventional therapies. Child psychiatrists are encouraged to stay tuned.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10553202

Source DB:  PubMed          Journal:  Child Adolesc Psychiatr Clin N Am        ISSN: 1056-4993


  4 in total

1.  Examining cortisol rhythmicity and responsivity to stress in children with Tourette syndrome.

Authors:  B A Corbett; S P Mendoza; C L Baym; S A Bunge; S Levine
Journal:  Psychoneuroendocrinology       Date:  2008-05-19       Impact factor: 4.905

Review 2.  Tourette syndrome: clinical characteristics and current management strategies.

Authors:  E H Kossoff; H S Singer
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 3.  Toxic threats to neurologic development of children.

Authors:  T Schettler
Journal:  Environ Health Perspect       Date:  2001-12       Impact factor: 9.031

4.  Brain-Immune Alterations and Mitochondrial Dysfunctions in a Mouse Model of Paediatric Autoimmune Disorder Associated with Streptococcus: Exacerbation by Chronic Psychosocial Stress.

Authors:  Maria Antonietta Ajmone-Cat; Chiara Spinello; Daniela Valenti; Francesca Franchi; Simone Macrì; Rosa Anna Vacca; Giovanni Laviola
Journal:  J Clin Med       Date:  2019-09-20       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.